Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 21, 2017 ) According to Publisher, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs has experienced robust market growth. Some of the factors which are triggering the market growth include growing incidences of diseases, rising demand for biosimilars drugs owing to their cost effectiveness and increasing demand to limit healthcare expenditures. However, stringent government regulations will affect biosimilars investments.
Chronic & Autoimmune disorders segment is expected to grow at a highest CAGR during the forecast period owing to increasing incidences of autoimmune disorders. By geography, Europe dominated the global biosimilars market due to growing appearance of new market participants in this region. However, Asia Pacific is anticipated to grow at a highest CAGR during the forecast period due to rising funds towards the expansion of biosimilars market. For more information @ http://www.reportsweb.com/biosimilar-global-market-outlook-2016-2022
Some of the key players in this market include are Mylan, Inc., Dr. Reddy's Laboratories, Amgen Inc., Sandoz International GmbH , Hospira, Inc., Merck KGAA, Celltrion, Inc., Biocon Ltd. , Teva Pharmaceutical Industries Ltd. and Roche Diagnostics.
Products Covered: - Peptides - Erythropoietin - Interferon - Human Growth Hormone - Monoclonal Antibodies - Granulocyte Colony Stimulating Factor (G-CSF) - Insulin - Other Products
Technology Covered: - Bioassay - Mass Spectrometry - Nuclear magnetic resonance (NMR) technology - Recombinant DNA Technology (rDNA technology) - Western Blotting - Electrophoresis - Chromatography - Monoclonal Antibodies (MAb) Technology
Application Covered: - Growth Hormone Deficiency - Chronic and Autoimmune Diseases - Blood Disorders - Oncology Diseases - Other Applications
Service Covered: - Clinical Trials - Contract Research and Manufacturing Services
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001564870/sample Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
11 Company Profiling 11.1 Mylan, Inc. 11.2 Dr. Reddy's Laboratories 11.3 Amgen Inc. 11.4 Sandoz International GmbH 11.5 Hospira, Inc. 11.6 Merck KGAA 11.7 Celltrion, Inc. 11.8 Biocon Ltd. 11.9 Teva Pharmaceutical Industries Ltd. 11.10 Roche Diagnostics 11.11 Biogen idec Inc. 11.12 LG Life Sciences 11.13 Synthon Pharmaceuticals, Inc. 11.14 Novartis AG
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001564870/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|